estriol has been researched along with Disease Exacerbation in 2 studies
hormonin: estrogen replacement; each tablet contains 600 ug micronized 17beta-estradiol, 270 ug estriol and 1.4 mg estrone
chlorapatite : A phosphate mineral with the formula Ca5(PO4)3Cl.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wharton, W | 1 |
| Gleason, CE | 1 |
| Miller, VM | 1 |
| Asthana, S | 1 |
| Yamanaka, Y | 1 |
| Matsuo, H | 1 |
| Kurachi, O | 1 |
| Oki, N | 1 |
| Nakago, S | 1 |
| Takeuchi, K | 1 |
| Maruo, T | 1 |
2 trials available for estriol and Disease Exacerbation
| Article | Year |
|---|---|
Rationale and design of the Kronos Early Estrogen Prevention Study (KEEPS) and the KEEPS Cognitive and Affective sub study (KEEPS Cog).
Topics: Adult; Atherosclerosis; Carotid Intima-Media Thickness; Cognition Disorders; Coronary Artery Disease | 2013 |
Effects of combined estriol/pravastatin therapy on intima-media thickness of common carotid artery in hyperlipidemic postmenopausal women.
Topics: Arteriosclerosis; Carotid Artery, Common; Disease Progression; Drug Therapy, Combination; Estriol; F | 2005 |